160 related articles for article (PubMed ID: 36290902)
1. The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases.
Wu L; Lu Y; Chen L; Yue X; Cen C; Zheng C; Han P
Curr Oncol; 2022 Oct; 29(10):7912-7924. PubMed ID: 36290902
[TBL] [Abstract][Full Text] [Related]
2. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract][Full Text] [Related]
3. The Efficacy of Radiotherapy in the Treatment of Hepatocellular Carcinoma with Distant Organ Metastasis.
Chen L; Wang Z; Song S; Sun T; Ren Y; Zhang W; Wang M; Liu Y; Zheng C
J Oncol; 2021; 2021():5190611. PubMed ID: 34840570
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
5. Preoperative radiotherapy improves overall survival of pT4 pancreatic ductal adenocarcinoma patients after surgical resection.
Xu Y; Zhang Y; Wu Z; Wang D; Wu W; Kuang T; Lou W
Jpn J Clin Oncol; 2020 Jun; 50(6):679-687. PubMed ID: 32372083
[TBL] [Abstract][Full Text] [Related]
6. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
[TBL] [Abstract][Full Text] [Related]
7. Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma.
Cao BY; Wang QQ; Zhang LT; Wu CC; Tong F; Yang W; Wang J
World J Gastrointest Oncol; 2023 Jan; 15(1):155-170. PubMed ID: 36684051
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database.
Luo C; Fan L; Lun W; Ma M; Liang L; Yu C
J Chemother; 2024 Apr; 36(2):167-178. PubMed ID: 38481380
[TBL] [Abstract][Full Text] [Related]
9. Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis.
He C; Zhang Y; Cai Z; Lin X
BMC Cancer; 2019 May; 19(1):509. PubMed ID: 31142278
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.
Worni M; Akushevich I; Gloor B; Scarborough J; Chino JP; Jacobs DO; Hahn SM; Clary BM; Pietrobon R; Shah A
Ann Surg Oncol; 2012 Apr; 19(4):1316-23. PubMed ID: 22002799
[TBL] [Abstract][Full Text] [Related]
11. Whether early stage pancreatic ductal adenocarcinoma patients could benefit from the post-operation chemotherapy regimens: a SEER-based propensity score matching study.
Shi J; Li X; Wu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 50(3):375-382. PubMed ID: 34402250
[TBL] [Abstract][Full Text] [Related]
12. The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision.
Xu B; Zhou Y; Pei Q; Tan F; Zhao L; Güngör C; Wang D; Li Y; Liu W; Zhou Z
J Cancer; 2022; 13(2):385-392. PubMed ID: 35069888
[No Abstract] [Full Text] [Related]
13. Comparison of the efficacy of pre-surgery and post-surgery radiotherapy in the treatment of hepatocellular carcinoma: a population-based study.
Chen L; Guo X; Chen S; Ren Y; Sun T; Yang F; Zheng C
Am J Transl Res; 2021; 13(1):360-371. PubMed ID: 33527030
[TBL] [Abstract][Full Text] [Related]
14. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
15. The Main Bottleneck for Non-Metastatic Pancreatic Adenocarcinoma in Past Decades: A Population-Based Analysis.
Li Y; Liu W; Zhao L; Xu Y; Yan T; Yang Q; Pei Q; Güngör C
Med Sci Monit; 2020 May; 26():e921515. PubMed ID: 32358953
[TBL] [Abstract][Full Text] [Related]
16. Ablation alone is noninferior to radiotherapy plus ablation in the patients with early-stage hepatocellular carcinoma: a population-based study.
Guo Y; Chen H; Wan J; Ren Y; Wu F; Chen L; Sun T; Yang L; Zheng C
Sci Rep; 2024 Jan; 14(1):1030. PubMed ID: 38200187
[TBL] [Abstract][Full Text] [Related]
17. The impact of different metastatic patterns on survival in patients with pancreatic cancer.
He C; Huang X; Zhang Y; Lin X; Li S
Pancreatology; 2021 Apr; 21(3):556-563. PubMed ID: 33518454
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
19. The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database.
Luo Y
Clin Transl Oncol; 2022 Jan; 24(1):76-83. PubMed ID: 34219204
[TBL] [Abstract][Full Text] [Related]
20. Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries.
Li Z; Zhang X; Sun C; Li Z; Fei H; Zhao D
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]